跳至主要内容
临床试验/RBR-2258hp5
RBR-2258hp5尚未招募2 期

Randomized clinical trial with topical use of Estradiol, Vaginal Dilator and the combination of both in the prevention of vaginal stenosis in women with cervical cancer after treatment with Radiotherapy

niversidade Estadual de Campinas0 个研究点开始时间: 2024年6月24日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 75Y(—)
性别
Female

入选标准

  • Women diagnosed with cervical cancer with disease stage I to IIIC2, who are recommended to undergo pelvic Radiotherapy treatment.

排除标准

  • Age under 18 or over 75 years old; use of hormonal therapy in the three months prior to inclusion; previous pelvic radiotherapy treatment; refuse to participate in the study; be under treatment or have been treated for breast or endometrial cancer from the time of inclusion; suspicion of neoplasm or hormone-dependent precursor lesion during study follow-up; personal history of thromboembolism or diagnosis of thrombophilia; current or recent history (less than 6 months) of angina or stroke or myocardial infarction; active liver disease; hypersensitivity to the components of the medications used in the study or the orthosis (dilator); porphyria; neurological diseases disabling the ability to follow study instructions; use of an implanted ferromagnetic defibrillator or pacemaker and cochlear implant

研究者

发起方
niversidade Estadual de Campinas

相似试验

The effectiveness of topical Estradiol, Vaginal... | 临床试验